Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Offer for Infast Group Update

20 Jun 2005 07:01

Eagerport Limited20 June 2005 Immediate Release 20 June 2005 This announcement is not for release, publication or distribution in or intoCanada, Australia or Japan. Recommended Cash Offer by KPMG Corporate Finance on behalf of the Offeror, a wholly owned indirect subsidiary of Anixter International Inc. and (in the United States) by the Offeror for Infast Group plc Extension of Offer and Level of Acceptances Further to the announcement on 26 May 2005 by Eagerport Limited (the "Offeror")of its Offer for all of the issued and to be issued ordinary share capital ofInfast Group plc ("Infast"), the Offeror announces that as at 1.00 p.m. (Londontime) on 17 June 2005, being the First Closing Date, it has received validacceptances of the Offer in respect of 95,644,845 Infast Shares, representing83.64 per cent of the entire existing issued ordinary share capital of Infast.The Offeror therefore announces it is extending the Offer for 21 days and thenext closing date for the Offer will be 1.00 p.m. (London time) on 8 July 2005. Included within these acceptances are acceptances in respect of 2,204,646 InfastShares, representing approximately 1.93 per cent of the entire existing issuedordinary share capital of Infast, which were the subject of irrevocableundertakings to accept the Offer from each of the Infast Directors in respect oftheir entire beneficial holdings of Infast Shares and the holdings of thosepersons connected with them. Also included within these acceptances are acceptances in respect of 57,826,516Infast Shares, representing approximately 50.57 per cent of the entire existingissued ordinary share capital of Infast, which were the subject of irrevocableundertakings to accept the Offer from certain other Infast Shareholders. As announced on 26 May 2005, the Offeror and Anixter received a non bindingletter of intent to accept the offer from Societe Generale Asset Management UKLimited in respect of 7,085,000 Infast Shares, representing approximately 6.20per cent of the entire existing issued ordinary share capital of Infast.Societe Generale Asset Management UK Limited announced on 31 May 2005 thatfollowing the sale of 2,150,000 Infast Shares on 27 May 2005, the number ofInfast Shares subject to the terms of this non-binding letter of intent was4,935,000. Whilst it is understood that Societe Generale Asset Management UKLimited have accepted the Offer in respect of their entire holding of 4,935,000Infast Shares, representing approximately 4.32 per cent of the entire existingissued ordinary share capital of Infast, it has not been possible to verify thisin the time available and further confirmation is being sought as to the extentto which the Societe Generale Asset Management UK Limited holding which is thesubject of the letter of intent is included in the valid acceptances referred toabove. A further announcement will be made as soon as practicable. Prior to the commencement of the Offer Period, neither the Offeror, nor anyperson deemed to be acting in concert with it, owned or controlled any InfastShares, or any rights over Infast Shares. Neither the Offeror, nor any persondeemed to be acting in concert with it, has acquired or agreed to acquire anyInfast Shares or any rights over Infast Shares during the Offer Period. Infast Shareholders who have not yet accepted the Offer, and who wish to do so,should accept the Offer as soon as possible and, in any event no later than 1.00p.m. (London time) on 8 July 2005. The procedures for acceptance of the Offerare set out on pages 14 to 16 of the Offer Document and in respect ofcertificated holders only, in the Form of Acceptance. Additional copies of theOffer Document and Form of Acceptance can be obtained from Capita Registrars(telephone 0870 162 3121, or +44 (0) 208 639 2157 if telephoning from outsidethe UK). Terms defined in the Offer Document dated 27 May 2005 have the same meaning inthis announcement save where the context requires otherwise. Enquiries: Anixter Dennis Letham Tel: +1 224 521 8601 KPMG Corporate Finance Charles E Cattaneo Tell: +44 (0) 121 232 3356 Buchanan Communications Charles Ryland Tel: +44 (0) 207 466 5000 James Strong Tel: +44 (0) 207 466 5000 KPMG Corporate Finance, a division of KPMG LLP which is authorised and regulatedby the Financial Services Authority for investment business activities, isacting for Anixter and the Offeror as financial adviser in relation to the Offerand is not acting for any other person in relation to the Offer. KPMG CorporateFinance will not be responsible to anyone other than Anixter and the Offeror forproviding the protections afforded to its clients or for providing advice inrelation to the contents of this announcement or any transaction or arrangementreferred to herein. This announcement does not constitute an offer or invitation to purchase anysecurities or the solicitation of an offer to buy any securities, pursuant tothe Offer or otherwise. The Offer is being made solely pursuant to the OfferDocument and the Form of Acceptance accompanying the Offer Document, whichcontain the full terms and conditions of the Offer, including details of how theOffer may be accepted. The Offer is not being made, directly or indirectly, in or into, or by use ofthe mails of, or by any means or instrumentality (including, without limitation,facsimile transmission, electronic mail, telex or telephone) of interstate orforeign commerce of, or any facilities of a national securities exchange ofCanada, Australia, Japan or any jurisdiction where to do so would violate thelaws in that jurisdiction and the Offer will not be capable of acceptance by anysuch use, means, instrumentality or facility, directly or indirectly from orwithin Canada, Australia, Japan or any such jurisdiction. The Offer in the United States is being made solely by the Offeror, and neitherKPMG LLP, KPMG Corporate Finance, nor any of its respective affiliates, ismaking the Offer in the United States. The members of the Anixter Offer Committee accept responsibility for theinformation contained in this announcement. To the best of the knowledge andbelief of the members of the Anixter Offer Committee (who have taken allreasonable care to ensure that such is the case), the information contained inthis announcement for which they accept responsibility is in accordance with thefacts and does not omit anything likely to affect the import of suchinformation. The Offeror Directors, accept responsibility for the information contained inthis announcement relating to the Offeror, the Offeror Directors and theirimmediate families and persons connected with them (within the meaning ofsection 346 of the Act). To the best of the knowledge and belief of the OfferorDirectors (who have taken all reasonable care to ensure that such is the case),the information contained in this announcement for which they acceptresponsibility is in accordance with the facts and does not omit anything likelyto affect the import of such information. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th May 20237:00 amRNSTransfer of ToxHub Platform and launch of Centrus®
11th May 20233:26 pmRNSHolding(s) in Company
11th May 20237:00 amRNSUS Government Contract Award
4th May 20235:07 pmRNSHolding(s) in Company
3rd May 20237:00 amRNSNotice of Results and Investor Presentation
2nd May 20234:13 pmRNSExercise of Options, Issue of Equity & TVR
14th Apr 20234:38 pmRNSHolding(s) in Company
13th Mar 20237:30 amRNSNo Exposure to Silicon Valley Bank
31st Jan 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSAppointment of Independent Non-Executive Director
5th Jan 20237:00 amRNSExercise of Options, Director/PDMR Dealing & TVR
22nd Dec 20227:00 amRNSContract Extension with Leading CRO
30th Nov 20225:48 pmRNSHolding(s) in Company
12th Oct 20227:00 amRNSExercise of Options, Issue of Equity and TVR
27th Sep 20227:01 amRNSHalf-year Report
27th Sep 20227:00 amRNSSettlement of Historical Licence Dispute
13th Sep 20227:00 amRNSNotice of Results and Investor Presentation
9th Sep 20223:49 pmRNSHolding(s) in Company
2nd Sep 20227:00 amRNS$12m five-year agreement with Leading CRO
4th Aug 20227:00 amRNSHalf Year Trading Update
29th Jun 20225:03 pmRNSHolding(s) in Company
9th Jun 20224:01 pmRNSResult of AGM
20th May 20224:31 pmRNSHolding(s) in Company
17th May 20227:00 amRNSNotice of AGM & Posting of Annual Report
3rd May 202212:00 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSEuropean Medicines Agency Research Grant
26th Apr 20224:40 pmRNSSecond Price Monitoring Extn
26th Apr 20224:35 pmRNSPrice Monitoring Extension
26th Apr 202210:15 amRNSEarn Outs and Deferred Payments
26th Apr 20229:54 amRNSFinal Results
26th Apr 20227:00 amRNSAnnouncement re: full year results
20th Apr 20229:05 amRNSNotice of Results & Investor Presentation
15th Mar 20221:49 pmRNSGrant of PDMR Options
14th Mar 20225:29 pmRNSExercise of Options, Issue of Equity and TVR
14th Mar 202211:22 amRNSHolding(s) in Company
22nd Feb 202210:15 amRNSHolding(s) in Company
4th Feb 20228:08 amRNSDirector/PDMR Shareholding
26th Jan 20227:00 amRNSTrading Update
11th Jan 20227:00 amRNSAppointment of Joint Broker
21st Dec 20217:00 amRNSH2 China Market Update
13th Dec 20214:55 pmRNSHolding(s) in Company
22nd Nov 20212:33 pmRNSHolding(s) in Company
22nd Nov 20217:00 amRNSNew In Silico Software Release
11th Oct 20213:15 pmRNSDirector/PDMR Shareholding
29th Sep 202110:34 amRNSHolding(s) in Company
29th Sep 20217:00 amRNSDirectorate Change
28th Sep 20217:00 amRNSGrant of PDMR Options
27th Sep 20217:00 amRNSHalf-year Report
14th Sep 20217:00 amRNSNotice of Results and Investor Presentation
14th Sep 20217:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.